418 related articles for article (PubMed ID: 29070069)
1. Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease.
Levelt E; Piechnik SK; Liu A; Wijesurendra RS; Mahmod M; Ariga R; Francis JM; Greiser A; Clarke K; Neubauer S; Ferreira VM; Karamitsos TD
J Cardiovasc Magn Reson; 2017 Oct; 19(1):81. PubMed ID: 29070069
[TBL] [Abstract][Full Text] [Related]
2. Adenosine Stress and Rest T1 Mapping Can Differentiate Between Ischemic, Infarcted, Remote, and Normal Myocardium Without the Need for Gadolinium Contrast Agents.
Liu A; Wijesurendra RS; Francis JM; Robson MD; Neubauer S; Piechnik SK; Ferreira VM
JACC Cardiovasc Imaging; 2016 Jan; 9(1):27-36. PubMed ID: 26684978
[TBL] [Abstract][Full Text] [Related]
3. Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study.
Mygind ND; Michelsen MM; Pena A; Qayyum AA; Frestad D; Christensen TE; Ghotbi AA; Dose N; Faber R; Vejlstrup N; Hasbak P; Kjaer A; Prescott E; Kastrup J;
J Cardiovasc Magn Reson; 2016 Nov; 18(1):76. PubMed ID: 27809867
[TBL] [Abstract][Full Text] [Related]
4. Adenosine stress native T1 mapping in severe aortic stenosis: evidence for a role of the intravascular compartment on myocardial T1 values.
Mahmod M; Piechnik SK; Levelt E; Ferreira VM; Francis JM; Lewis A; Pal N; Dass S; Ashrafian H; Neubauer S; Karamitsos TD
J Cardiovasc Magn Reson; 2014 Nov; 16(1):92. PubMed ID: 25410203
[TBL] [Abstract][Full Text] [Related]
5. Quantitative cardiovascular magnetic resonance perfusion imaging identifies reduced flow reserve in microvascular coronary artery disease.
Zorach B; Shaw PW; Bourque J; Kuruvilla S; Balfour PC; Yang Y; Mathew R; Pan J; Gonzalez JA; Taylor AM; Meyer CH; Epstein FH; Kramer CM; Salerno M
J Cardiovasc Magn Reson; 2018 Feb; 20(1):14. PubMed ID: 29471856
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium-Free Cardiac MR Stress T1-Mapping to Distinguish Epicardial From Microvascular Coronary Disease.
Liu A; Wijesurendra RS; Liu JM; Greiser A; Jerosch-Herold M; Forfar JC; Channon KM; Piechnik SK; Neubauer S; Kharbanda RK; Ferreira VM
J Am Coll Cardiol; 2018 Mar; 71(9):957-968. PubMed ID: 29495995
[TBL] [Abstract][Full Text] [Related]
7. Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
Gulsin GS; Shetye A; Khoo J; Swarbrick DJ; Levelt E; Lai FY; Squire IB; Arnold JR; McCann GP
BMC Cardiovasc Disord; 2017 Apr; 17(1):98. PubMed ID: 28390413
[TBL] [Abstract][Full Text] [Related]
8. Automated Pixel-Wise Quantitative Myocardial Perfusion Mapping by CMR to Detect Obstructive Coronary Artery Disease and Coronary Microvascular Dysfunction: Validation Against Invasive Coronary Physiology.
Kotecha T; Martinez-Naharro A; Boldrini M; Knight D; Hawkins P; Kalra S; Patel D; Coghlan G; Moon J; Plein S; Lockie T; Rakhit R; Patel N; Xue H; Kellman P; Fontana M
JACC Cardiovasc Imaging; 2019 Oct; 12(10):1958-1969. PubMed ID: 30772231
[TBL] [Abstract][Full Text] [Related]
9. Sub-segmental quantification of single (stress)-pass perfusion CMR improves the diagnostic accuracy for detection of obstructive coronary artery disease.
Le MTP; Zarinabad N; D'Angelo T; Mia I; Heinke R; Vogl TJ; Zeiher A; Nagel E; Puntmann VO
J Cardiovasc Magn Reson; 2020 Feb; 22(1):14. PubMed ID: 32028980
[TBL] [Abstract][Full Text] [Related]
10. Stress Perfusion CMR in Patients With Known and Suspected CAD: Prognostic Value and Optimal Ischemic Threshold for Revascularization.
Vincenti G; Masci PG; Monney P; Rutz T; Hugelshofer S; Gaxherri M; Muller O; Iglesias JF; Eeckhout E; Lorenzoni V; Pellaton C; Sierro C; Schwitter J
JACC Cardiovasc Imaging; 2017 May; 10(5):526-537. PubMed ID: 28412420
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus and coronary microvascular function in asymptomatic patients with severe aortic stenosis and nonobstructed coronary arteries.
Banovic M; Brkovic V; Nedeljkovic I; Nedeljkovic M; Popovic D; Djordjevic-Dikic A; Ristic A; Nikolic S; Beleslin B
Diab Vasc Dis Res; 2016 May; 13(3):220-7. PubMed ID: 26993497
[TBL] [Abstract][Full Text] [Related]
12. Utility of stress perfusion-cardiac magnetic resonance in follow-up of patients undergoing percutaneous coronary interventions of the left main coronary artery.
Nanni S; Lovato L; Ghetti G; Vagnarelli F; Mineo G; Fattori R; Saia F; Marzocchi A; Marrozzini C; Zompatori M; Reggiani LB; Semprini F; Melandri G; Biagini E; Corsini A; Norscini G; Rapezzi C
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1589-1597. PubMed ID: 28455632
[TBL] [Abstract][Full Text] [Related]
13. Splenic T1-mapping: a novel quantitative method for assessing adenosine stress adequacy for cardiovascular magnetic resonance.
Liu A; Wijesurendra RS; Ariga R; Mahmod M; Levelt E; Greiser A; Petrou M; Krasopoulos G; Forfar JC; Kharbanda RK; Channon KM; Neubauer S; Piechnik SK; Ferreira VM
J Cardiovasc Magn Reson; 2017 Jan; 19(1):1. PubMed ID: 28081721
[TBL] [Abstract][Full Text] [Related]
14. The reliability and feasibility of non-contrast adenosine stress cardiovascular magnetic resonance T1 mapping in patients on haemodialysis.
Poli FE; Gulsin GS; March DS; Abdelaty AM; Parke KS; Wormleighton JV; McCann GP; Burton JO; Graham-Brown MP
J Cardiovasc Magn Reson; 2020 Jun; 22(1):43. PubMed ID: 32507107
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular subclinical myocardial dysfunction in uncomplicated type 2 diabetes mellitus is associated with impaired myocardial perfusion: a contrast-enhanced cardiovascular magnetic resonance study.
Liu X; Yang ZG; Gao Y; Xie LJ; Jiang L; Hu BY; Diao KY; Shi K; Xu HY; Shen MT; Ren Y; Guo YK
Cardiovasc Diabetol; 2018 Oct; 17(1):139. PubMed ID: 30373588
[TBL] [Abstract][Full Text] [Related]
16. Cardiac magnetic resonance for asymptomatic patients with type 2 diabetes and cardiovascular high risk (CATCH): a pilot study.
Ng MY; Zhou W; Vardhanabhuti V; Lee CH; Yu EYT; Wan EYF; Chan K; Yan AT; Ip TP; Yiu KH; Wintersperger BJ
Cardiovasc Diabetol; 2020 Mar; 19(1):42. PubMed ID: 32234045
[TBL] [Abstract][Full Text] [Related]
17. T1 reactivity as an imaging biomarker in myocardial tissue characterization discriminating normal, ischemic and infarcted myocardium.
van Assen M; van Dijk R; Kuijpers D; Vliegenthart R; Oudkerk M
Int J Cardiovasc Imaging; 2019 Jul; 35(7):1319-1325. PubMed ID: 31093894
[TBL] [Abstract][Full Text] [Related]
18. Microvascular Dysfunction in Dilated Cardiomyopathy: A Quantitative Stress Perfusion Cardiovascular Magnetic Resonance Study.
Gulati A; Ismail TF; Ali A; Hsu LY; Gonçalves C; Ismail NA; Krishnathasan K; Davendralingam N; Ferreira P; Halliday BP; Jones DA; Wage R; Newsome S; Gatehouse P; Firmin D; Jabbour A; Assomull RG; Mathur A; Pennell DJ; Arai AE; Prasad SK
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1699-1708. PubMed ID: 30660522
[TBL] [Abstract][Full Text] [Related]
19. Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping.
van Dijk R; Kuijpers D; Kaandorp TAM; van Dijkman PRM; Vliegenthart R; van der Harst P; Oudkerk M
Int J Cardiovasc Imaging; 2017 Nov; 33(11):1753-1759. PubMed ID: 28547666
[TBL] [Abstract][Full Text] [Related]
20. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
